Skip to content
★ Sign in to follow
PW

Paul W. Hoelscher

Chief Financial Officer
Horizon Therapeutics Public Ltd Co
Total declarations
81
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (18 ops.)
€56.7M

Latest filing published 22 Apr 2022 for Horizon Therapeutics Public Ltd Co, €3.0M.

Filing timeline

BuySale
Paul W. Hoelscher

Insider track record

Disclosed buys
0
Disclosed sells
18
Signal history

Paul W. Hoelscher: trading record in brief

All filings by Paul W. Hoelscher on record concern Horizon Therapeutics Public Ltd Co, in the capacity of finance chief. Between 23 June 2015 and 20 April 2022, the trades on record add up to 81 filings.

Sales make up the whole of the open-market record (18 sales, €56.7M). Other entries cover 27 share grants and 21 option exercises. Since January 2022: no purchases and 8 sales on the market.

The newest entry dates from 22 April 2022: an open-market sale of €3.0M, in Horizon Therapeutics Public Ltd Co. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Paul W. Hoelscher

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations81 total

25 of 81 declarations